Michael Y. Shapira - Concepedia

Author

Michael Y. Shapira

Also Known As

M Shapira, M Y Shapira, M. Shapira, M. Y Shapira, M. Y. Shapira, M.Y. Shapira, MICHAEL Y. SHAPIRA, Michael Shapira, Michael Y Shapira, Michael Y. Shapira

123

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Hadassah Medical Center Hebrew University of Jerusalem Hadassah Academic College Bar-Ilan University Tel Aviv University

About

Michael Y. Shapira is an author at Hadassah Medical Center specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	1.1K
2	Health Sciences	6	6	204
3	Public Health	1	1	13
4	Allergy	1	1	28
5	Allergy Medicine	1	1	28

Michael Y. Shapira

Publications

Citations

H-Index

Page 1

	Year	Citations
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase Reuven Or, Michael Y. Shapira, Igor Resnick, Blood	2002	213
Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation Michael Y. Shapira, Igor Resnick, Sunwen Chou, Clinical Infectious Diseases Cytomegalovirus InfectionTransplantationViral PersistenceHematologyAntiviral Response	2008	154
Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial Birte Friedrichs, André Tichelli, Andrea Bacigalupo, The Lancet Oncology TransplantationMarrow TransplantationBone Marrow FailureRandomised TrialStem Cell Transplantation	2010	134
A decision analysis: The dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation Elad Sharon, Todd Thierer, Menachem Bitan, Oral Oncology Cytotoxic TherapyMarrow TransplantationStem Cell TransplantationHematologyPrimary Care Dentistry	2007	131
Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC). Igor Resnick, Claudine Barkats, Michael Y. Shapira, PubMed	2013	118
Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine Michael Y. Shapira, Evelyn Zeira, Ruth Adler, Journal of Hepatology VaccinationRapid SeroprotectionViral HepatitisFirst DoseHepatitis B	2001	69
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimen Igor Resnick, Memet Aker, Michael Y. Shapira, British Journal of Haematology	2006	56
Phase I/<scp>II</scp> study exploring ImMucin, a pan‐major histocompatibility complex, anti‐<scp>MUC</scp>1 signal peptide vaccine, in multiple myeloma patients Lior Carmon, Irit Avivi, Riva Kovjazin, British Journal of Haematology	2014	56
Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients Elad Sharon, Adi A. Garfunkel, Reuven Or, Supportive Care in Cancer TransplantationMarrow TransplantationStem Cell TransplantationHematologyTransplantation Medicine	2003	53
Fludarabine-Based Reduced Intensity Conditioning for Stem Cell Transplantation of Fanconi Anemia Patients from Fully Matched Related and Unrelated Donors Menachem Bitan, Reuven Or, Michael Y. Shapira, Biology of Blood and Marrow Transplantation Cell TherapyTransplantation MedicineImmunologyFully Matched RelatedFanconi Anemia Patients	2006	50

Page 1